CIK 0001576280 · Large accelerated filer
Guardant Health, Inc.
Sign in to watch- Ticker
- GH
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454139254
- Phone
- 855-698-8887
- Business address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,739,100
- in 9 filings, $213K under 10b5-1 plans
Net −$9,739,100. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | Freeman Chris Chief Commercial Officer | Option exercise | +1,667 | 57,167 | ||
| 2026-04-01 | Freeman Chris Chief Commercial Officer | Option exercise | +2,526 | 59,693 | ||
| 2026-04-01 | Freeman Chris Chief Commercial Officer | Option exercise | +5,091 | 64,784 | ||
| 2026-04-01 | Freeman Chris Chief Commercial Officer | Shares withheld for taxes | −4,750 | $91.15 | $433K | 60,034 |
| 2026-04-01 | Freeman Chris Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,929 | 3,857 | ||
| 2026-04-01 | Freeman Chris Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,667 | 3,335 | ||
| 2026-04-01 | Freeman Chris Chief Commercial Officer | Option exercise · Restricted Stock Units | −2,526 | 15,158 | ||
| 2026-04-01 | Freeman Chris Chief Commercial Officer | Option exercise · Restricted Stock Units | −5,091 | 10,339 | ||
| 2026-04-01 | Talasaz AmirAli Co-Chief Executive Officer | Option exercise | +23,997 | 2,153,875 | ||
| 2026-04-01 | Talasaz AmirAli Co-Chief Executive Officer | Option exercise | +9,716 | 2,163,591 | ||
| 2026-04-01 | Talasaz AmirAli Co-Chief Executive Officer | Shares withheld for taxes | −17,087 | $91.15 | $1.6M | 2,146,504 |
| 2026-04-01 | Talasaz AmirAli Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −23,997 | 71,992 | ||
| 2026-04-01 | Talasaz AmirAli Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −9,716 | 68,011 | ||
| 2026-04-01 | Eltoukhy Helmy Co-Chief Executive Officer | Option exercise | +23,997 | 2,120,290 | ||
| 2026-04-01 | Eltoukhy Helmy Co-Chief Executive Officer | Option exercise | +9,716 | 2,130,006 | ||
| 2026-04-01 | Eltoukhy Helmy Co-Chief Executive Officer | Shares withheld for taxes | −17,087 | $91.15 | $1.6M | 2,112,919 |
| 2026-04-01 | Eltoukhy Helmy Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −23,997 | 71,992 | ||
| 2026-04-01 | Eltoukhy Helmy Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −9,716 | 68,011 | ||
| 2026-04-01 | Saia John G. Chief Legal Officer | Option exercise | +974 | 57,877 | ||
| 2026-04-01 | Saia John G. Chief Legal Officer | Option exercise | +1,667 | 59,544 |
Page 19 of 22 · 421 trades